RA Capital Management

We're excited to share that Elizabeth Jochum, Director of Robotics and Automation at RA Capital, will be speaking at Robotics Invest in Boston next week! 🤖 📅 Tuesday, May 27 📍 Panel: AI Driving the Physical World Elizabeth will be joined by an incredible lineup of robotics leaders: • Ariyan Kabir, Co-Founder & CEO, GrayMatter Robotics • Etienne Lacroix, Founder & CEO, Vention • Matt Miesnieks, Stealth Company AI is rapidly moving from the digital world into the physical one — reshaping manufacturing, logistics, healthcare, and beyond. This panel will dig into what that transformation really looks like and where the biggest opportunities lie. If you're attending Robotics Invest, make sure to catch this one. See you in Boston! 📍 #RoboticsInvest #Robotics #AI #Automation #RACapital

We're excited to share that Rajeev Shah, Managing Partner at RA Capital, will be speaking this week at the RAD (RARE Advocate Development) Brain Workshop hosted by Global Genes🌟 This is a must-attend session for rare disease advocates, patient organizations, and anyone navigating the intersection of science, capital, and patient impact. 📅 Friday, May 22 🕒 10:00 AM 📍 Panel: Finance, Partnering, and Raising Capital Raj will be joined by Walter Kowtoniuk, PhD (Third Rock Ventures) and Yael Weiss (Mahzi) for a candid conversation covering: • The current investment environment for rare disease • How top-tier venture firms approach rare disease investing • Recent investments and success stories • Practical guidance for patient advocacy groups looking to fund therapy development Learn more here: https://lnkd.in/gsXwkzW5 #TheRareVoice #RADWorkshop2026 #RareEpilepsyNetwork #GlobalGenes #PatientAdvocacy #CNSDisorders #RareDiseaseLeadership

It's exciting when a company like Sana Biotechnology, Inc. closes a successful funding round. But it's even more exciting to think about what that funding might enable for the millions of people living with type 1 diabetes (#T1D) worldwide. If you or someone you know is managing #T1D, daily life can be a relentless, merciless calculus of glucose, insulin, and worry. Today’s pumps and sensors have eased the load, but Sana Biotechnology, Inc. is working diligently on a #hypoimmune platform - the platform this funding will help them further develop - that offers a shot at something more: their science indicates a real chance at freedom from the unending T1D calculus without the cost and risks associated with lifelong immunosuppression. Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We know them to be a passionate group of people working to change how the world treats disease. RA Capital is proud to support their efforts and we are inspired by the potential for their innovations to transform the lives of people living with #T1D. https://lnkd.in/e5Bxz3Z5

Next week, RA Capital's own Senior Health Economist, Richard Z. Xie, will be taking the stage at ISPOR—The Professional Society for Health Economics and Outcomes Research 2026 three times in Philadelphia — and his topics are timely. 🌟 📅 Monday, May 18 🕒 4:45 – 5:45 PM 📍 The Metrics Behind the Money: Case Studies and Insights From Bridging Health Economics and Investment Richard will join Mel Whittington, Meng Li, and Sorochi Van Sickle for a deep dive into how health economics and investment decision-making intersect in practice. 📅 Tuesday, May 19 🕒 1:45 – 2:45 PM 📍 Incorporating Patient, Family, and Public Perspectives to Advance Novel and Societal Elements of Value in Value Assessment Richard will join Meng Li, Julia Slejko, and Jingyan Yang to explore how patient and societal perspectives can reshape how we think about value in healthcare. 📅 Tuesday, May 19 🕒 4:45 – 5:45 PM 📍 Beyond the Usual First Launch: Making Differential Pricing Work for Innovative NCD Medicines in Middle-Income Countries Richard will join Mikkel Oestergaard, Kalipso Chalkidou, and Prashant Yadav to address one of global health's most pressing access challenges. Three panels. Two days. One very busy Richard. 😄 Haven't registered yet? Register here: https://lnkd.in/dv8Z74_5 And if you're already attending ISPOR, we hope you'll catch one (or all three) of Richard's sessions. See you in Philly! #ISPOR2026 #HealthEconomics #HEOR #ValueAssessment #GlobalHealth #RACapital

We are proud to be among the firms that co-hosted #Science2Startup 2026. It was a real privilege to share the room with this group of founders and the people backing them. Thank you to our fellow host firms, presenters, sponsors, and everyone who makes this possible year-after-year!

Zoey was born with cystic fibrosis. A generation ago, kids like her often didn't live past their teens. In 2019, Vertex launched Trikafta, a drug that changed her life. It also costs over $300,000 a year. Is that price fair? Is the company greedy? Is the healthcare system broken? Too many people — including a lot of people who work in biotech — can't confidently answer those questions, and that's the gap Biotech Unveiled was built to close. Biotech Unveiled is a free, self-paced, 9-chapter mini-course from Peter Kolchinsky (RA Capital, author of The Great American Drug Deal) that explains how the biotech ecosystem works: where new drugs come from, how they get funded, why they're priced the way they are, how generics eventually make them cheap forever, and where the healthcare system genuinely fails patients. (hint: it's usually not where the headlines point!) Complete the course, and you'll be able to answer these questions and more. Pass the final exam, and you'll get a certificate for your LinkedIn profile! Register now: https://lnkd.in/ev6F37ne

Cross-border collaboration must be a core capability if we're to efficiently and quickly advance important medicines to patients in the US and around the world. Thanks to our friends at Biosparc and True Light for co-hosting this important dialogue! https://bit.ly/4uy4nUD

CellCentric is working to advance inobrodib to create what could be a new treatment option for patients suffering from multiple myeloma, and we're proud to support their efforts. https://bit.ly/4uxQfLb

"For every generation, vaccines work." #WorldImmunizationWeek was last week, but it's never a bad time to reflect on these powerful public health tools that have saved more than 150 million lives over the past ~50 years. Our continued progress against preventable disease relies in part on a better public understanding of vaccines' safety and effectiveness, and so we'd like to reshare "A Vaccine For Your Mind" from RA Capital's infectious disease team. "Medicine is complicated, and the current discourse is noisy, but it’s possible to bridge the gap between experts and patients by breaking down the jargon." Read their full piece here: https://lnkd.in/gmT7M_dK And please share this report with friends, family, or anyone who has questions about vaccination.

https://bit.ly/4w9vpTV We have to solve the challenge of how people will be able to age well in their homes. Emotionally intelligent robots seem like an an elegant part of the solution, so we invested in one of the best teams in the world to tackle that challenge. Yesterday, Familiar Machines & Magic emerged from stealth at the Wall Street Journal's #futureofeverything event, and we're excited to support them as they explore the health and quality of life applications for these robots in and outside our homes. Congratulations to Colin Angle and the entire team at Familiar!